Meribank Biotech Co., Ltd. (4724)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
8. 94
-0.03
-0.3344%
NT$
1.47B Market Cap
- P/E Ratio
- Div Yield
74,558 Volume
- Eps
NT$ 8.97
Previous Close Want to track 4724 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Meribank Biotech Co., Ltd. (4724) Statistics
Valuation metrics
Market Cap 1.47B
Enterprise value 1.89B
Trailing P/E (ttm) -9.93
Forward P/E -
PEG ratio -0.86
Price/Sales (ttm) 1.82
Price/Book (mrq) 0.66
Enterprise Value/Revenue 4
Enterprise Value/EBITDA 32.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 53.44K
Average volume (90 days) 165.43K
Price summary
52-Week low 8.52
52-Week high 24.75
Beta -
50-Day moving average 9.75
200-Day moving average 12.58
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.17%
Operating margin -0.14%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.88
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.48
Total debt (mrq) -
Total Debt/Equity (mrq) 0.9
Current ratio (mrq) 1.9%
Book value per share (mrq) 13.64
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
